<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-22601-2S4KN</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">A costimulatory power-boost for HIV-specific T-cells through GITR activation</narrative>
  </title>
  <description type="3">
   <narrative xml:lang="EN">Our findings will reach researchers worldwide that are involved in T cell physiology in general and HIV-specific immunotherapy in particular.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">People infected with HIV have nowadays almost the average life expectancy of the general population. However, not all individuals control the infection well with the current therapies, and eventually progress towards AIDS. The HIV research community believes that the immune system from these individuals is still partially functional, and optimized stimulation regiments could help suppress the disease progression. We propose here that additional activation pathways, i.e., costimulation, can be used as a powerful immunotherapy to boost the functionality of HIV-specific T cells. Increasing the effector function of HIV-specific T cells can open new opportunities to halt the progression to AIDS in patients that fail to control the chronic infection with standard treatments.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="EN">T-cell responses are critical to control HIV replication, yet not all individuals achieve viral control via their T-cells. In fact, high viral load correlates with poor T-cell functionality and high expression of inhibitory receptors in HIV-specific T-cells. Checkpoint blockade immunotherapies, aimed at  blocking inhibitory receptors, have proven very effective in increasing anti-tumor T-cell function in different cancers, suggesting that this strategy could also be translated to HIV. However, clinical data from cancer patients indicate that blocking one pathway is not sufficient to fully restore T-cell function. Combined therapy that influences several non-redundant pathways will be a more effective approach.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">The main goal is to enhance functionality of HIV-specific T-cells by triggering the GITR costimulatory pathway. First, we will assess if GITR expression can be induced in attenuated HIV-specific T-cells. We will focus on the progressors, which will most likely benefit from this treatment, because their T-cells are the most dysfunctional. If GITR can be expressed by the virus-specific T-cells, we will trigger it &#x2013;alone or in combination with blockade of inhibitory pathways- and determine the functionality. The choice of functional readouts will be based in described alterations in T-cells from HIV progressors.</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41217565" role="4" type="80">
   <narrative xml:lang="EN">Sanquin Research</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2017-08-01" type="1"></activity-date>
  <activity-date iso-date="2018-12-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <recipient-country code="NL" percentage="100"></recipient-country>
  <location>
   <name>
    <narrative xml:lang="EN">Amsterdam</narrative>
   </name>
  </location>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">A costimulatory power-boost for HIV-specific T-cells through GITR activation STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2017-08-01"></period-start>
   <period-end iso-date="2018-12-01"></period-end>
   <value currency="EUR" value-date="2017-08-01">74800</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-11-24"></transaction-date>
   <value currency="EUR" value-date="2017-11-24">67320</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-41204333">
    <narrative xml:lang="EN">AMR Amsterdam</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-11-24"></transaction-date>
   <value currency="EUR" value-date="2017-11-24">67320</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-41204333">
    <narrative xml:lang="EN">AMR Amsterdam</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-07-24"></transaction-date>
   <value currency="EUR" value-date="2019-07-24">7480</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-41217565">
    <narrative xml:lang="EN">Sanquin Research</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-25"></transaction-date>
   <value currency="EUR" value-date="2019-07-25">7480</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-41217565">
    <narrative xml:lang="EN">Sanquin Research</narrative>
   </receiver-org>
  </transaction>
 </iati-activity>
</iati-activities>
